<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03499782</url>
  </required_header>
  <id_info>
    <org_study_id>XHEC-JDYXY-2018-002</org_study_id>
    <nct_id>NCT03499782</nct_id>
  </id_info>
  <brief_title>Precise Treatment System of Biliary Malignancies Based on Special Disease Database</brief_title>
  <official_title>A Multi-center Study：Surgical Optimization and Prognosis Auxiliary System of Biliary Malignancies Based on Special Disease Database</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>First Affiliated Hospital Xi'an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Zhengzhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Dalian Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Southwest Hospital, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin Medical University Cancer Institute and Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Afﬁliated Hospital of North Sichuan Medical College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Eastern Hepatobiliary Surgery Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Malignant tumors of biliary system lack standard treatment and precise prognosis assessment
      methods. This study including 12 hospitals, collecting clinical and follow-up data of
      patients with biliary malignant tumors including cholangiocarcinoma and gallbladder carcinoma
      in recent 10 years, aim to build a special disease database, then use Bayesian networks and
      importance theory to establish a mathematical model to assess treatment strategies and
      prognosis accurately. At the same time, data on biliary malignant tumors newly treated by
      multicenters from 2018 to 2020 will be included to validate, adjust and refine the models to
      guide clinical individualized precise treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">May 25, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Death from biliary tract carcinoma</measure>
    <time_frame>Every three months, up to five years</time_frame>
    <description>Death from cholangiocarcinoma or gallbladder carcinoma</description>
  </primary_outcome>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Cholangiocarcinoma</condition>
  <condition>Gall Bladder Carcinoma</condition>
  <condition>Biliary System Disorder</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients Diagnosed with Gallbladder carcinoma or cholangiocarcinoma
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria：

          -  Clinical diagnosis of biliary malignancy including gallbladder carcinoma or
             cholangiocarcinoma verified by pathological results

          -  Must be able to undergo surgery

          -  Undergoing radical surgery for biliary malignancy (R0 or R1 resection)

          -  Not complicated with other malignancy

          -  No other treatments before and during surgery, such as radiotherapy and chemotherapy.

        Exclusion Criteria:

          -  Non-primary gallbladder or cholangiocarcinoma

          -  With distant metastasis (M1 phase)

          -  Incomplete follow-up data

          -  Died within 30 days after surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhimin Geng, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>the first affiliated hospital of xi'an Jiaotong univerisity</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peng Gong, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>the first affiliated hospital of Dalian medical univerisity</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yu He, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>Southwest Hospital, China</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shengping Li, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>Cancer Institute and Hospital Affiliated to Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yinghe Qiu, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>Eastern Hepatobiliary Surgery Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zhi Dai, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>Shanghai Zhongshan Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tianqiang Song, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>Tianjin Medical University Cancer Institute and Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yudong Qiu, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jianying Lou, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>Second Affiliated Hospital, School of Medicine, Zhejiang University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jingdong Li, MD,PdD</last_name>
    <role>Study Director</role>
    <affiliation>Affliated Hospital of North Sichuan Medical College</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wenlong Zhai, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>The First Affiliated Hospital of Zhengzhou University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhaohui Tang, MD,PhD</last_name>
    <phone>+86 13601789458</phone>
    <email>tangzhaohui@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Miaoyan Wei, MD,PhD</last_name>
    <phone>+86 18516574578</phone>
    <email>doctor_vmy@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhaohui Tang</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200092</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miaoyan Wei</last_name>
      <phone>+86 18516574578</phone>
      <email>doctor_vmy@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Zhaohiu Tang Tang</last_name>
      <phone>+8613601789458</phone>
      <email>tangzhaohui@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 8, 2018</study_first_submitted>
  <study_first_submitted_qc>April 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2018</study_first_posted>
  <last_update_submitted>April 13, 2018</last_update_submitted>
  <last_update_submitted_qc>April 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</investigator_affiliation>
    <investigator_full_name>Zhaohui Tang</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Prognosis</keyword>
  <keyword>Surgery options</keyword>
  <keyword>Bayesian networks</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholangiocarcinoma</mesh_term>
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

